| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 10.55▼ | 10.61▼ | 10.54▼ | 10.15▲ | 10.72▼ |
| MA10 | 10.58▼ | 10.46▲ | 10.28▲ | 10.37▲ | 11.37▼ |
| MA20 | 10.60▼ | 10.21▲ | 10.09▲ | 10.70▼ | 11.83▼ |
| MA50 | 10.53▼ | 10.13▲ | 10.27▲ | 11.53▼ | 9.94▲ |
| MA100 | 10.26▲ | 10.30▲ | 10.56▼ | 11.99▼ | 15.17▼ |
| MA200 | 10.07▲ | 10.58▼ | 10.68▼ | 10.45▲ | 24.74▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.021▼ | 0.056▲ | 0.093▲ | -0.009▼ | -0.301▼ |
| RSI | 43.895▼ | 60.142▲ | 59.012▲ | 45.690▼ | 45.172▼ |
| STOCH | 37.828 | 52.724 | 66.971 | 17.055▼ | 15.167▼ |
| WILL %R | -80.000▼ | -52.727 | -52.727 | -53.293 | -83.682▼ |
| CCI | -149.145▼ | 47.326 | 81.071 | -4.239 | -85.261 |
|
Friday, May 01, 2026 10:20 AM
Pfizer (PFE) stock and Arvinas (ARVN) stock are in focus as the FDA approves the companies' breast cancer drug, Veppanu. Read more here.
|
|
Friday, May 01, 2026 10:09 AM
VEPPANU™ is the first-and-only FDA-approved PROTAC, a type of heterobifunctional protein degrader –– Approval received in advance of ...
|
|
Friday, May 01, 2026 10:09 AM
VEPPANU™ is the first-and-only FDA-approved PROTAC, a type of heterobifunctional protein degrader –– Approval received in advance of ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 01/05/26 | 9.75 | 11.40 | 9.73 | 10.51 | 2,147,210 |
| 30/04/26 | 9.95 | 10.08 | 9.74 | 9.90 | 489,005 |
| 29/04/26 | 10.09 | 10.09 | 9.80 | 9.82 | 587,903 |
| 28/04/26 | 10.38 | 10.51 | 10.165 | 10.22 | 428,489 |
| 27/04/26 | 10.42 | 10.79 | 10.22 | 10.29 | 398,638 |
| 24/04/26 | 10.39 | 10.515 | 10.15 | 10.44 | 567,467 |
| 23/04/26 | 10.69 | 10.72 | 10.30 | 10.42 | 524,266 |
| 22/04/26 | 10.70 | 10.735 | 10.515 | 10.63 | 626,172 |
| 21/04/26 | 10.80 | 10.81 | 10.52 | 10.62 | 640,897 |
| 20/04/26 | 10.815 | 11.04 | 10.71 | 10.81 | 517,209 |
|
|
||||
|
|
||||
|
|